Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on A49, A52, and Litenimod Sodium for Patients with Glioblastoma
FranceLong-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat
BelgiumStudy on Monitoring Ocrelizumab Levels for Personalized Treatment in Patients with Relapsing-Remitting and Primary Progressive Multiple Sclerosis
CzechiaStudy of Autologous Cord Blood Stem Cells Treatment for Newborns with Hypoxic-Ischemic Encephalopathy
FranceStudy Comparing the Effects of Ozanimod and Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis
ItalyStudy on the Effects of IMU-838 (Vidofludimus Calcium) for Patients with Relapsing-Remitting Multiple Sclerosis
BulgariaStudy on [18F]Fluoro-PEG-Folate Imaging for Patients with Giant Cell Arteritis
The NetherlandsStudy on Esketamine Hydrochloride and Sodium Chloride for Patients with Severe Acute Brain Injury
DenmarkStudy on the Effects of Sodium Lactate and Electrolyte Solution in Comatose Patients After Cardiac Arrest
BelgiumStudy on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis
BulgariaStudy on Cluster Headache Using Befiradol (18F) for Patients with Episodic Symptoms
FranceStudy on Intra-Arterial Thrombolysis with Alteplase for Patients with Acute Ischemic Stroke in the Anterior Circulation
FranceThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
